Press Release Feb 28 2022

Published February 28, 2022 at 4:10 p.m. UTC

Unichem Laboratories Limited has informed the Exchange about press release dated 28-Feb-2022 titled ANDA Approval for Divalproex Sodium Extended-Release Tablets USP, 250 mg and 500 mg

View Attachment

4:["$","main",null,{"className":"seo-shell seo-template-news","children":[["$","script",null,{"type":"application/ld+json","className":"seo-jsonld","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Press Release Feb 28 2022\",\"description\":\"Unichem Laboratories Limited has informed the Exchange about press release dated 28-Feb-2022 titled ANDA Approval for Divalproex Sodium Extended-Release Tablets USP, 250 mg and 500 mg\",\"url\":\"https://6ix.com/news/press-release-feb-28-2022-11\",\"datePublished\":\"2022-02-28T16:10:20.000Z\",\"articleSection\":\"Business\",\"about\":{\"@type\":\"Corporation\",\"name\":\"Unichem Laboratories Limited\",\"url\":\"https://6ix.com/stock/nse-unichemlab/unichem-laboratories-limited\",\"tickerSymbol\":\"NSE:UNICHEMLAB\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"6ix\",\"url\":\"https://6ix.com\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https://6ix.com/images/social-banner.png?v=2\"}}}"}}],["$","div",null,{"className":"seo-page-frame","children":[null,[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"$d"}}],["$","div",null,{"dangerouslySetInnerHTML":{"__html":"$e"}}]]]}]]}] 7:null